Back
ESC Premium Access

Efficacy and safety of didpeptidyl peptidase 4 inhibitors and sodium-glucose linked cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis

Session: Improving diabetes outcomes: beyond glucocentricity
Topic: Diabetes management
Speaker: Associate Professor G. Savarese (Stockholm, SE)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Associate Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
38 presentations
5 followers

7 more presentations in this session

Excess risk of heart failure among persons with type 2 diabetes

Speaker: Professor A. Rosengren (Goteborg, SE)

Access
Abstract
Slides
Video
Thumbnail

Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation

Speaker: Doctor H. Yokoi (Fukuoka, JP)

Access
Abstract
Slides
Video
Thumbnail

Histone 3 lysine 27 trimethylation in type 2 diabetes: a novel potential pharmacological target in diabetic foot ulcer treatment

Speaker: Doctor M. Colognesi-Capogrossi (Rome, IT)

Access
Abstract
Slides
Video
Thumbnail

Nephro-protective effects of Dapagliflozin in patients with type 2 diabetes

Speaker: Doctor M. Nakayama (Toda, JP)

Access
Abstract
Slides
Video
Thumbnail

Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography

Speaker: Doctor B. Zafrir (Haifa, IL)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Improving diabetes outcomes: beyond glucocentricity

Speakers: Associate Professor G. Savarese, Professor A. Rosengren, Doctor H. Yokoi, Doctor M. Colognesi-Capogrossi, Doctor M. Nakayama...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb